A Study to Evaluate the Tolerability, Safety, Pharmacokinetics of HEC89736 in Patients With Relapsed or Refractory B-cell Hematologic Malignancies
Clinical trial NCT04865458 · TERMINATED
Trial details
- NCT number
- NCT04865458
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2022-09-21
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.